LANXESS AG

Lanxess AG shifts to delivery‑first strategy amid Middle East tension, but weak 2026 guidance sparks investor worry and stock volatility.

LANXESS AG’s latest filings and market moves reveal regulatory compliance and cautious growth prospects in specialty chemicals, metalworking fluids, and nylon‑66 demand.

LANXESS AG’s steep drop to €21.28 and a negative P/E signals investor doubt—short‑selling spikes and a costly share release raise questions about future profitability in the volatile chemicals sector. Explore what it means for investors and the comp…

LANXESS AG stock drops 57% from peak, shows 28.7% loss over a year, high short‑selling activity, and negative P/E – what drives the fall and recovery?

Lanxess AG faces a tough 2025 outlook as demand weakens and cost‑cutting ramps up—will its efficiency drive restore margins and investor confidence?

German chemical company LANXESS AG has lowered its profit outlook due to economic headwinds and unpredictable US trade policy, affecting the broader chemical industry.

LANXESS AG’s stock has been impacted by recent market movements and short-selling activity, with the company’s shares experiencing a decline despite a broader market positive response to US inflation data.